Canaccord Genuity Reaffirms Their Buy Rating on Allogene Therapeutics (ALLO)
Canaccord Genuity analyst John Newman maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report) today and set a price target of ...
Canaccord Genuity Group Forecasts Strong Price Appreciation for Middleby (NASDAQ:MIDD) Stock
Middleby (NASDAQ:MIDD – Get Free Report) had its price objective increased by equities research analysts at Canaccord Genuity ...
Canaccord Genuity Group Forecasts Strong Price Appreciation for Stride (NYSE:LRN) Stock
Stride (NYSE:LRN – Get Free Report) had its price target increased by investment analysts at Canaccord Genuity Group from ...
IGO (IPGDF) Gets a Sell from Canaccord Genuity
Canaccord Genuity analyst Timothy Hoff maintained a Sell rating on IGO (IPGDF – Research Report) on January 24 and set a price target of ...
Super Group Shares Climb After Canaccord Praises Investments, Raises Rating
Shares of Super Group rose after Canaccord Genuity raised its rating for the digital gaming and entertainment company, lauding its efforts to retreat from the U.S. sports-betting market. Super Group's ...